CEO: Arthur Tzianabos

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Homology Medicines is an US based genetic medicines company. It is dedicated towards translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases.


Key numbers

Market Capitalization:763566900
Shares Outstanding: 44035000
Float: 30181633
Next Earning Date:2020-03-17
TTm EPS: -2.4317
TTm Dividend Rate:
200 days moving average:18.66
50 days moving average: 17.39
One day percent Change: -1.53



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,